
Technology used to produce the Covid vaccine has been shown to cut the risk of cancer tumours returning, new research has shown.
Pharmaceutical firms Moderna and MSD are working on a personalised cancer vaccine, designed to prime the immune system so the body can generate a response based on a person’s specific type of cancer tumour.